{"id":"https://openalex.org/W2085122016","doi":"https://doi.org/10.1021/jm030217e","title":"Imidazoquinoxaline Src-Family Kinase p56Lck Inhibitors: SAR, QSAR, and the Discovery of (S)-N-(2-Chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-a]pyrido[3,2-e]pyrazin-6-amine (BMS-279700) as a Potent and Orally Active Inhibitor with Excellent in Vivo Antiinflammatory Activity","display_name":"Imidazoquinoxaline Src-Family Kinase p56Lck Inhibitors: SAR, QSAR, and the Discovery of (S)-N-(2-Chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-a]pyrido[3,2-e]pyrazin-6-amine (BMS-279700) as a Potent and Orally Active Inhibitor with Excellent in Vivo Antiinflammatory Activity","publication_year":2004,"publication_date":"2004-07-27","ids":{"openalex":"https://openalex.org/W2085122016","doi":"https://doi.org/10.1021/jm030217e","mag":"2085122016","pmid":"https://pubmed.ncbi.nlm.nih.gov/15317463"},"language":"en","primary_location":{"id":"doi:10.1021/jm030217e","doi":"https://doi.org/10.1021/jm030217e","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm030217e","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100400321","display_name":"Ping Chen","orcid":"https://orcid.org/0000-0003-0274-5674","observed_orcids":["https://orcid.org/0000-0003-0274-5674"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ping Chen","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005544895","display_name":"Arthur M. Doweyko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arthur M. Doweyko","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029005835","display_name":"Derek J. Norris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Derek Norris","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080548419","display_name":"Henry H. Gu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Henry H. Gu","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038748688","display_name":"Steven H. Spergel","orcid":"https://orcid.org/0000-0002-5190-3942","observed_orcids":["https://orcid.org/0000-0002-5190-3942"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven H. Spergel","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006264129","display_name":"Jagabundhu Das","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jagabundhu Das","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027235259","display_name":"Robert V. Moquin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert V. Moquin","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000781041","display_name":"James C. Lin","orcid":"https://orcid.org/0000-0002-7848-9841","observed_orcids":["https://orcid.org/0000-0002-7848-9841"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Lin","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083770969","display_name":"John Wityak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Wityak","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045292739","display_name":"Edwin J. Iwanowicz","orcid":"https://orcid.org/0009-0005-0690-3301","observed_orcids":["https://orcid.org/0009-0005-0690-3301"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edwin J. Iwanowicz","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057731792","display_name":"Kim W. McIntyre","orcid":"https://orcid.org/0000-0002-4791-2731","observed_orcids":["https://orcid.org/0000-0002-4791-2731"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kim W. McIntyre","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036271380","display_name":"David J. Shuster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J. Shuster","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046815152","display_name":"Kamelia Behnia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kamelia Behnia","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103666754","display_name":"Saeho Chong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saeho Chong","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111550490","display_name":"Henry F. De Fex","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Henry de Fex","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025115770","display_name":"Suhong Pang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suhong Pang","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063499402","display_name":"Sydney Pitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sydney Pitt","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031887391","display_name":"Ding Ren Shen","orcid":"https://orcid.org/0000-0002-3336-1836","observed_orcids":["https://orcid.org/0000-0002-3336-1836"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ding Ren Shen","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073806371","display_name":"Sara H. Thrall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara Thrall","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057785080","display_name":"Paul Stanley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Stanley","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072980310","display_name":"Octavian Kocy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Octavian R. Kocy","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034870696","display_name":"Mark R. Witmer","orcid":"https://orcid.org/0009-0005-6860-0920","observed_orcids":["https://orcid.org/0009-0005-6860-0920"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark R. Witmer","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084399396","display_name":"Steven Brian Kanner","orcid":"https://orcid.org/0000-0002-7698-9113","observed_orcids":["https://orcid.org/0000-0002-7698-9113","https://orcid.org/0009-0003-7790-4307"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven B. Kanner","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060371965","display_name":"Gary L. Schieven","orcid":"https://orcid.org/0009-0004-4830-9020","observed_orcids":["https://orcid.org/0009-0004-4830-9020"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary L. Schieven","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042299848","display_name":"Joel C. Barrish","orcid":"https://orcid.org/0009-0001-7351-1261","observed_orcids":["https://orcid.org/0009-0001-7351-1261"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel C. Barrish","raw_affiliation_strings":["Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5100400321"],"corresponding_institution_ids":["https://openalex.org/I4210091812"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.2281,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.86400243,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"47","issue":"18","first_page":"4517","last_page":"4529"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/src-family-kinases","display_name":"Src family kinases","score":0.9020000100135803},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7839999794960022},{"id":"https://openalex.org/keywords/qsar","display_name":"QSAR","score":0.7049999833106995},{"id":"https://openalex.org/keywords/t-cell-proliferation","display_name":"T cell proliferation","score":0.6830000281333923},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7419999837875366},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.9179999828338623},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.765999972820282},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9629999995231628},{"id":"https://openalex.org/keywords/hydrogen-bonding","display_name":"hydrogen bonding","score":0.6589999794960022},{"id":"https://openalex.org/keywords/steric-and-electronic-effects","display_name":"steric and electronic effects","score":0.6420000195503235},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8908601999282837},{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.8349677324295044},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5887905359268188},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4566033184528351},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23988524079322815}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006860","descriptor_name":"Hydrogen Bonding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019061","descriptor_name":"src-Family Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D019860","descriptor_name":"Lymphocyte Specific Protein Tyrosine Kinase p56(lck)","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D021281","descriptor_name":"Quantitative Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm030217e","doi":"https://doi.org/10.1021/jm030217e","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm030217e","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:15317463","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15317463","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1479891216","https://openalex.org/W1519301821","https://openalex.org/W1596485921","https://openalex.org/W1975166327","https://openalex.org/W1977663795","https://openalex.org/W1982114584","https://openalex.org/W2009631795","https://openalex.org/W2009667440","https://openalex.org/W2009915012","https://openalex.org/W2012916558","https://openalex.org/W2018028519","https://openalex.org/W2030131622","https://openalex.org/W2031504111","https://openalex.org/W2035562653","https://openalex.org/W2043287930","https://openalex.org/W2047517404","https://openalex.org/W2049492313","https://openalex.org/W2051043780","https://openalex.org/W2053709445","https://openalex.org/W2055607705","https://openalex.org/W2057069307","https://openalex.org/W2058413420","https://openalex.org/W2058661551","https://openalex.org/W2059553672","https://openalex.org/W2065289702","https://openalex.org/W2067318014","https://openalex.org/W2070943458","https://openalex.org/W2075451080","https://openalex.org/W2077333548","https://openalex.org/W2079127998","https://openalex.org/W2080653934","https://openalex.org/W2081019360","https://openalex.org/W2090501101","https://openalex.org/W2090895449","https://openalex.org/W2096579230","https://openalex.org/W2122149778","https://openalex.org/W2125554395","https://openalex.org/W2140592033","https://openalex.org/W2144935474","https://openalex.org/W2170992468","https://openalex.org/W2174520807","https://openalex.org/W2184963582","https://openalex.org/W2186444379","https://openalex.org/W2319957449","https://openalex.org/W2328587823","https://openalex.org/W2333391546","https://openalex.org/W2949429200","https://openalex.org/W2949496522","https://openalex.org/W4230663824"],"related_works":["https://openalex.org/W2172845845","https://openalex.org/W2174260023","https://openalex.org/W2049492313","https://openalex.org/W2032819022","https://openalex.org/W2124524255","https://openalex.org/W2180771765","https://openalex.org/W3034316987","https://openalex.org/W2255520827","https://openalex.org/W2039090007","https://openalex.org/W2762525527"],"abstract_inverted_index":{"A":[0],"series":[1,83],"of":[2,28,42,55,65],"novel":[3],"anilino":[4],"5-azaimidazoquinoxaline":[5],"analogues":[6],"possessing":[7],"potent":[8],"in":[9,48],"vitro":[10],"activity":[11],"against":[12],"p56Lck":[13],"and":[14,46,68],"T":[15],"cell":[16],"proliferation":[17],"have":[18],"been":[19],"discovered.":[20],"Subsequent":[21],"SAR":[22],"studies":[23],"led":[24],"to":[25,75,86],"the":[26,40,63],"identification":[27],"compound":[29],"4":[30],"(BMS-279700)":[31],"as":[32],"an":[33,52],"orally":[34],"active":[35],"lead":[36],"candidate":[37],"that":[38],"blocks":[39],"production":[41],"proinflammatory":[43],"cytokines":[44],"(IL-2":[45],"TNFalpha)":[47],"vivo.":[49],"In":[50],"addition,":[51],"expanded":[53],"set":[54],"imidazoquinoxalines":[56],"provided":[57],"several":[58],"descriptive":[59],"QSAR":[60],"models":[61],"highlighting":[62],"influence":[64],"significant":[66],"steric":[67],"electronic":[69],"features.":[70],"The":[71],"H-bonding":[72],"(Met319)":[73],"contribution":[74],"observed":[76],"binding":[77],"affinities":[78],"within":[79],"a":[80],"tightly":[81],"congeneric":[82],"was":[84],"found":[85],"be":[87],"significant.":[88]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}